Greta Smith

Greta Smith 2014 photo

Research Officer

Phone: +64 9 921 9999 ext7676

Email: greta.smith@aut.ac.nz

Physical Address:

Room AB105, AUT North Shore Campus, 90 Akoranga Drive, Northcote 0627, Auckland, New Zealand



Postal Address:

Person Centred Research Centre
School of Clinical Sciences
Faculty of Health and Environmental Sciences
AUT University, Private Bag 92006, Auckland 1142





Address for blogs:
Facebook Living Well Health Disability page

Links to relevant web pages:
www.aut.ac.nz/pcrc

Publications:

  1. Damjanovic, D., Riley, G., Thompson, P., Sharples, K., & Findlay, M. (2004). Sequential double-doublet chemotherapy given either all first line or split first and second line in patients with advanced colorectal cancer (CRC). A Randomised Phase II/III Study Proposal.
  2. Doak, J., Dhillon, H., Riley, G., Jeffery, M., Sharples, K., Koea, J., et al. (2004). Cancer Trials New Zealand (CTNZ) – Protocol Development Process. . In New Zealand Society of Oncology Annual Meeting (Ed.).
  3. Findlay, M., Damianovich, D., & Riley, G. (2004). Sequential double-doublet chemotherapy given either all first line or split and second line in patients with advanced colorectal cancer (CRC): A randomised phase II/III study. In New Zealand Society of Oncology Annual Meeting (Ed.).
  4. Findlay, M., Riley, G., & Ackland, S. (2002). A Phase I PK study of Capecitabine and Oral Cyclophosphamide in Patients with Advanced Cancer, Proc Am Soc Clin Oncol 165a (abstr 2151).
  5. Findlay, M., Riley, G., Ackland, S., Simpson, A., Isaacs, R., Mahoney, G., et al. (2002). Capecitabine and oral cyclophosphamide: a novel oral treatment combination for advanced cancer, Annals of Oncology . Vol. 13(4): 24.
  6. Findlay, M., Sharples, K., Riley, G., Simpson, A., Ackland, S., Hall, K., et al. (2007). Capecitabine and oral cyclophosphamide: A novel oral treatment combination for advanced cancer. Asia-Pacific Journal of Clinical Oncology, 3(2), 99-105.
  7. Fitzharris, P., & Riley, G. (1999). House dust mites in atopic dermatitis. International Journal of Dermatology, 38(3), 173-175.
  8. Harvey, V., Dzhelali, M., Isaacs, R., Jameson, M., Jeffery, M., McKeage, M., et al. (2004). Cyclox II – A Randomised Phase II Study of all Oral Chemotherapy in Advanced Breast Cancer. . In New Zealand Society of Oncology Annual Meeting (Ed.).
  9. Harvey, V. J., Sharples, K., Isaacs, R., Jameson, M. B., Jeffery, M., McLaren, B., et al. (2008). A randomized phase II study comparing capecitabine (C) with C plus oral cyclophosphamide (CCy) in patients (pts) with advanced breast cancer (BC). J Clin Oncol (Meeting Abstracts), 26(15 suppl), 1077.
  10. Helsby, N., Lo, W.-Y., K Sharples, K., Riley, G., Murray, M., Spells, K., et al. (2008). CYP2C19 pharmacogenetics in advanced cancer: Compromised function independent of genotype. British Journal of Cancer, 99, 1251-1225.
  11. Holloway, J. W., Dunbar, P. R., Riley, G. A., Sawyer, G. M., Fitzharris, P. F., Pearce, N., et al. (2000). Association of beta2-adrenergic receptor polymorphisms with severe asthma. Clinical & Experimental Allergy, 30(8), 1097-1103.
  12. Hook, S., Cheng, P., Holloway, J., Riley, G., Sawyer, G., Le Gros, G., et al. (1999). Analysis of two IL-4 promoter polymorphisms in a cohort of atopic and asthmatic subjects. Experimental & Clinical Immunogenetics, 16(1), 33-35.
  13. Liu, J. J., Kestell, P., Findlay, M., Riley, G., Ackland, S., Simpson, A., et al. (2004). Application of liquid chromatography-mass spectrometry to monitoring plasma cyclophosphamide levels in phase I trial cancer patients. Clinical & Experimental Pharmacology & Physiology, 31(10), 677-682.
  14. Mason, K., Riley, G., Siebers, R., Crane, J., & Fitzharris, P. (1999). Hot tumble drying and mite survival in duvets. Journal of Allergy & Clinical Immunology, 104(2 Pt 1), 499-500.
  15. McPherson, K., Fadyl, J., Kayes, N., Smith, G., Rutherford, S., Bright, F., et al. (2009). Measuring work-ability and return-to-work outcomes in rehabiltiation workshop. In Accident Compensation Corporation (Ed.). Wellington.
  16. McPherson, K., & Riley, G. (2007). Expanded findings report May 2007 in association with the Evaluation of Vocational Rehabilitation under the IPRC Act 2001 Report February 2007
  17. McPherson, K. M., Kayes, N., Fadyl, J., Smith, G. A., Moloczij, N., & Kersten, P. (2009). Reviews of Return to Work and Prevention of Work Disability - Final Report (A report commissioned by the Accident Compensation Corporation New Zealand). Auckland: AUT University.
  18. McPherson, K. M., Kayes, N. M., Fadyl, J., & Smith, G. (2008). Exploring research evidence: Drivers of rehabilitation performance. Unpublished Invited speaker: Drivers of ACC Rehabilitation Performance – Research and Operations Workshop.
  19. McPherson, K. M., Kayes, N. M., Fadyl, J., Smith, G., Moloczji, N., & Kersten, P. (2009). Work and Disability Review Findings. Unpublished Invited speaker: Accident Compensation Corporation Workshop.
  20. Moloczij, N., McPherson, K., Smith, J., & Kayes, N. (2008). Help seeking at the time of stroke: Stroke survivors' perspectives on their decisions Health and Social Care in the Community, 16(5), 501-510.
  21. Moloczij, N., McPherson, K., Smith, J., & Kayes, N. (2009 ). Help seeking at the time of stroke: Stroke survivors' perspectives on their decisions: Podcast for the International Program of Psycho-Social Health Research, CQUniversity.
  22. Moloczij, N., McPherson, K. M., Smith, J. F., & Kayes, N. M. (2005, 17 - 19 November 2005). Help seeking at the time of stroke: Patients perspectives on their decision. . Paper presented at the New Zealand Rehabilitation Association Conference, Auckland, New Zealand
  23. Moloczij, N., Payne, D., & Smith, J. (2009, 4-5 May). Sustaining one’s own health and wellness while supporting a stroke survivor: Spouses’ and partners’ perspectives. Paper presented at the 25th Annual Pacific Rim International Conference on Disabilities Hawaii, Honolulu.
  24. Nye, K. E., Riley, G. A., & Pinching, A. J. (1992). The defect seen in the phosphatidylinositol hydrolysis pathway in HIV-infected lymphocytes and lymphoblastoid cells is due to inhibition of the inositol 1,4,5-trisphosphate 1,3,4,5-tetrakisphosphate 5-phosphomonoesterase.[erratum appears in Clin Exp Immunol 1992 Oct;90(1):160]. Clinical & Experimental Immunology, 89(1), 89-93.
  25. Nye, K. E., Riley, G. A., Poulter, L. W., Porfiri, E., Hoffbrand, A. V., & Wickremasinghe, R. G. (1992). Impaired degradation of Ca(2+)-regulating second messengers in myeloid leukemia cells. Implications for the regulation of leukemia cell proliferation. Leukemia, 6(8), 801-805.
  26. Riley, G., Siebers, R., Rains, N., Crane, J., & Fitzharris, P. (1998). House-dust mite antigen on skin and sheets. Lancet, 351(9103), 649-650.
  27. Wickens, K., Lane, J. M., Fitzharris, P., Siebers, R., Riley, G., Douwes, J., et al. (2002). Farm residence and exposures and the risk of allergic diseases in New Zealand children.[see comment]. Allergy, 57(12), 1171-1179.


Last updated: 04-Nov-2015 5.00pm

The information on this page was correct at time of publication. For a comprehensive overview of AUT qualifications, please refer to the Academic Calendar.